Prelude Therapeutics Incorporated Analysis
| Analyst Ratings |
|
Average Target Price
|
9.60
|
|
Average Rating
|
3.40
|
|
# Strong Buys
|
1
|
|
# Buys
|
1
|
|
# Holds
|
2
|
|
# Sells
|
1
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.64
|
-0.63
|
0.01
|
1.56%
|
|
2022-06-30
|
-0.61
|
-0.58
|
0.03
|
4.92%
|
|
2022-03-31
|
-0.65
|
-0.63
|
0.02
|
3.08%
|
|
2021-12-31
|
-0.68
|
-0.71
|
-0.03
|
-4.41%
|
|
2021-09-30
|
-0.62
|
-0.66
|
-0.04
|
-6.45%
|
|
2021-06-30
|
-0.49
|
-0.58
|
-0.09
|
-18.37%
|
|
2021-03-31
|
-0.42
|
-0.47
|
-0.05
|
-11.90%
|
|
2020-12-31
|
-0.47
|
-0.45
|
0.02
|
4.26%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.84
|
|
2021-12-31
|
-2.42
|
|
2020-12-31
|
-11.20
|